Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furst

Showing results (261-270 of 755) with videos related to

Pageof 76
Sort By:
Clinical and Experimental Rheumatology|June 14, 2012
Clinical trial design in scleroderma: where are we and where do we go next?Lorinda Chung, Christopher P Denton, Oliver Distler, et al.
Rheumatology (Oxford, England)|February 11, 2010
Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trialPuja P Khanna, Daniel E Furst, Philip J Clements, et al.
Arthritis and Rheumatism|July 1, 1981
The arthropathy of advanced progressive systemic sclerosis. A radiographic surveyK L Blocka, L W Bassett, D E Furst, et al.
The American Journal of Medicine|July 1, 1981
The relationship arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS)P J Clements, D E Furst, W Cabeen, et al.
The Journal of Rheumatology|December 7, 2005
A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritisDaniel E Furst, Roy Fleischmann, Elliott Kopp, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 1, 2012
Satisfaction and access to clinical care in a rheumatology clinic at a large urban medical centerHarsh Agrawal, M Cameron Hay, Elizabeth R Volkmann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1978
Metabolism of meseclazone in manS H Dromgoole, K E Nyman, D E Furst, et al.
Arthritis and Rheumatism|November 1, 1991
Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosisP J Clements, P A Lachenbruch, D E Furst, et al.
Journal of Pharmaceutical Sciences|December 1, 1983
Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humansT N Tozer, J G Gambertoglio, D E Furst, et al.
Arthritis and Rheumatism|February 1, 1989
Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel diseaseS C Ng, P J Clements, W E Berquist, et al.
Pageof 76

Showing results (261-270 of 755) with videos related to

Sort By:
Pageof 76
Clinical and Experimental Rheumatology|June 14, 2012
Clinical trial design in scleroderma: where are we and where do we go next?Lorinda Chung, Christopher P Denton, Oliver Distler, et al.
Rheumatology (Oxford, England)|February 11, 2010
Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trialPuja P Khanna, Daniel E Furst, Philip J Clements, et al.
Arthritis and Rheumatism|July 1, 1981
The arthropathy of advanced progressive systemic sclerosis. A radiographic surveyK L Blocka, L W Bassett, D E Furst, et al.
The American Journal of Medicine|July 1, 1981
The relationship arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS)P J Clements, D E Furst, W Cabeen, et al.
The Journal of Rheumatology|December 7, 2005
A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritisDaniel E Furst, Roy Fleischmann, Elliott Kopp, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 1, 2012
Satisfaction and access to clinical care in a rheumatology clinic at a large urban medical centerHarsh Agrawal, M Cameron Hay, Elizabeth R Volkmann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1978
Metabolism of meseclazone in manS H Dromgoole, K E Nyman, D E Furst, et al.
Arthritis and Rheumatism|November 1, 1991
Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosisP J Clements, P A Lachenbruch, D E Furst, et al.
Journal of Pharmaceutical Sciences|December 1, 1983
Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humansT N Tozer, J G Gambertoglio, D E Furst, et al.
Arthritis and Rheumatism|February 1, 1989
Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel diseaseS C Ng, P J Clements, W E Berquist, et al.
Pageof 76